Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 19/20 | 0.59 |
| ▸ | NPY1R | P25929 | 11/20 | 0.59 |
| ▸ | NPY5R | Q15761 | 10/20 | 0.59 |
| ▸ | NPY2R | P49146 | 7/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29531964 | 0.92 | NPY4R (0.53) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL29872146 | 0.89 | NPY4R (0.53) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL31437162 | 0.89 | NPY4R (0.54) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL14753920 | 0.89 | NPY4R (0.58) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL24306611 | 0.88 | NPY4R (0.57) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL17950964 | 0.88 | NPY4R (0.57) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL30213589 | 0.88 | NPY4R (0.52) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL30611008 | 0.88 | NPY4R (0.54) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL30371101 | 0.87 | NPY4R (0.52) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL30471796 | 0.87 | NPY4R (0.52) | NPY4RNPY1RNPY5RNPY2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022133586-A1 | METFORMIN PREVENTS HYPERGLYCAEMIA-ASSOCIATED, OXIDATIVE STRESS-INDUCED VASCULAR ENDOTHELIAL DYSFUNCTION: ESSENTIAL ROLE FOR THE ORPHAN NUCLEAR RECEPTOR, NR4A1 (NUR77) | UTI LIMITED PARTNERSHIP (CA) | 2022-06-30 | — | — | WO | disclosed |